Q1 2025 · 13F-HR
Finepoint Capital LPholdings as filed
Filed 2025-05-14 · accession 0000904454-25-000272
$1.31B
Reported value
25
Positions
2025-03-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 78462F103 | SPY | SPDR S&P 500 ETF TR | $422.2M | 32.2% | 755,000 | PUT | SOLE |
| 82846H405 | QXO | QXO INC | $331.3M | 25.3% | 24,468,160 | Common | SOLE |
| 464287655 | IWM | ISHARES TR | $296.3M | 22.6% | 1,485,000 | PUT | SOLE |
| 530307305 | LBRDK | Liberty Broadband Corp | $45.0M | 3.43% | 529,240 | Common | SOLE |
| 85205L107 | SWTXUSD | SPRINGWORKS THERAPEUTICS INC | $32.2M | 2.45% | 728,602 | Common | SOLE |
| 531229722 | LLYVK* | LIBERTY MEDIA CORP DEL | $29.5M | 2.25% | 432,895 | Common | SOLE |
| 04351P101 | ASNDUSD | ASCENDIS PHARMA A/S | $28.0M | 2.14% | 179,872 | Common | SOLE |
| 76155X100 | RVMD | REVOLUTION MEDICINES INC | $24.4M | 1.86% | 691,260 | Common | SOLE |
| 61559X104 | MLTX | MoonLake Immunotherapeutics | $17.0M | 1.30% | 435,785 | Common | SOLE |
| 36315X101 | LKFT | GALAPAGOS NV | $16.5M | 1.26% | 656,587 | Common | SOLE |
| 23282W605 | CYTK | CYTOKINETICS INC | $12.5M | 0.95% | 309,948 | Common | SOLE |
| 05370A108 | RNAGBP | AVIDITY BIOSCIENCES INC | $11.2M | 0.86% | 380,700 | Common | SOLE |
| 803607100 | SRPT | SAREPTA THERAPEUTICS INC | $10.1M | 0.77% | 157,555 | Common | SOLE |
| G72800108 | PRTA | PROTHENA CORP PLC | $7.9M | 0.60% | 640,071 | Common | SOLE |
| 98401F105 | XNCR | XENCOR INC | $6.8M | 0.52% | 642,200 | Common | SOLE |
| 30233G209 | EYPT | EYEPOINT PHARMACEUTICALS INC | $5.9M | 0.45% | 1,081,954 | Common | SOLE |
| 75943R102 | RLAY | RELAY THERAPEUTICS INC | $5.5M | 0.42% | 2,117,646 | Common | SOLE |
| 04335A105 | ARVN | ARVINAS INC | $4.9M | 0.37% | 694,028 | Common | SOLE |
| 83422E204 | SLDB | SOLID BIOSCIENCES INC | $3.6M | 0.27% | 961,251 | Common | SOLE |
| 01444V103 | ANNA | ALEANNA INC | $208,709 | 0.02% | 27,717 | Common | SOLE |
| 01444V111 | ANNAW | ALEANNA INC | $122,451 | 0.01% | 490,000 | Common | SOLE |
| 56608A113 | — | Marblegate Acquisition Corp | $117,600 | 0.01% | 735,000 | Common | SOLE |
| G6202B119 | MNYWW | MONEYHERO LIMITED | $32,847 | 0.00% | 895,000 | Common | SOLE |
| G9845F117 | LSBWF | LAKESHORE BIOPHARMA CO LTD | $20,237 | 0.00% | 489,999 | Common | SOLE |
| 320703309 | — | CALIDI BIOTHERAPEUTICS INC | $7,077 | 0.00% | 12,499 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.